(Total Views: 210)
Posted On: 09/08/2020 9:10:14 PM
Post# of 36541
https://www.theedgemarkets.com/article/vaccin...r-interest
Mechanical and electrical engineering works specialist Bintai Kinden has seen its share price rise more than fourfold, after it signed an MoU with vaccine research firm NuGenerex Immuno-Oncology (Generex) to fund and manage a synthetic peptide vaccine for Covid-19. Generex is principally involved in robust research and development into the creation of on-demand peptide vaccines to control pandemic viruses.
Mechanical and electrical engineering works specialist Bintai Kinden has seen its share price rise more than fourfold, after it signed an MoU with vaccine research firm NuGenerex Immuno-Oncology (Generex) to fund and manage a synthetic peptide vaccine for Covid-19. Generex is principally involved in robust research and development into the creation of on-demand peptide vaccines to control pandemic viruses.
(0)
(0)Scroll down for more posts ▼
